Polyrizon partners with Clearmind to develop intranasal MEAI formulation
Go back to Polyrizon partners with Clearmind to develop intranasal MEAI formulation| (NASDAQ: CMND) | Delayed: 1.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.16 | 52 Week High | $ | |||
| Open | $1.16 | 52 Week Low | $ | |||
| Day High | $1.16 | P/E | N/A | |||
| Day Low | $1.16 | EPS | $ | |||
| Volume | 51,820 | |||||
| (NASDAQ: PLRZ) | Delayed: 11.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.24 | 52 Week High | $ | |||
| Open | $11.24 | 52 Week Low | $ | |||
| Day High | $11.24 | P/E | N/A | |||
| Day Low | $11.24 | EPS | $ | |||
| Volume | 110 | |||||

